Curaleaf Holdings (CURLF) Enterprise Value (2019 - 2025)
Curaleaf Holdings (CURLF) posted quarterly Enterprise Value of -$101.6 million for Q4 2025, up 5.27% year-on-year from -$96.5 million in Q4 2024, and up 5.27% on a QoQ basis from -$107.2 million in Q4 2024.
Curaleaf Holdings (CURLF) Enterprise Value (2019 - 2025) Analysis & Trends
Curaleaf Holdings (CURLF) has reported Enterprise Value for 7 consecutive years, with -$101.6 million the latest figure, recorded in Q4 2025.
- Quarterly Enterprise Value rose 5.27% year-over-year to -$101.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$101.6 million (up 5.27% YoY) and the FY2025 annual result came in at -$101.6 million, up 5.27% from the prior year.
- Enterprise Value advanced to -$101.6 million in Q4 2025 per CURLF's latest filing, from -$107.2 million in the prior quarter.
- Over the last five years, Enterprise Value for CURLF reached as high as $116.5 billion in Q1 2022 and fell as low as -$312.5 million in Q1 2021.
- A 5-year average of $7.7 billion and a median of $24.9 million in 2024 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value jumped 37395.09% — and 2024, when it slumped 471.9%.
- Year by year, Enterprise Value stood at $45.4 million in 2021, then tumbled by 192.59% to -$42.1 million in 2022, then surged by 168.54% to $28.8 million in 2023, then sank by 471.9% to -$107.2 million in 2024, then gained by 5.27% to -$101.6 million in 2025.
- According to Business Quant data, Enterprise Value over the past three periods registered -$101.6 million, -$107.2 million, and $35.8 million for Q4 2025, Q4 2024, and Q3 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -2.15 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -428.00 Mn |
| 10 | Curaleaf Holdings | 7.13 Bn | 7.13 Bn | 157.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -101.57 Mn |
| Dec 31, 2024 | -107.23 Mn |
| Sep 30, 2024 | 35.77 Mn |
| Jun 30, 2024 | 24.94 Mn |
| Dec 31, 2023 | 28.83 Mn |
| Sep 30, 2023 | 1.17 Mn |
| Jun 30, 2023 | 38.28 Mn |
| Dec 31, 2022 | -42.06 Mn |
| Sep 30, 2022 | 118.02 Mn |
| Jun 30, 2022 | 112.14 Mn |
| Mar 31, 2022 | 116.55 Bn |
| Dec 31, 2021 | 45.43 Mn |
| Sep 30, 2021 | -191.28 Mn |
| Jun 30, 2021 | -203.42 Mn |
| Mar 31, 2021 | -312.50 Mn |
| Dec 31, 2020 | -71.45 Mn |
| Sep 30, 2020 | -82.66 Mn |
| Dec 31, 2019 | -44.93 Mn |